Atlas Trials

QoL-Comparison Between Trabectedin/PLD and Pt-based Therapy in Patients With Pt-sensitive Recurrent Ovarian Cancer

Clinical trial NCT03164980 · TERMINATED

Trial details

NCT number
NCT03164980
Sponsor
North Eastern German Society of Gynaecological Oncology
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Quality of LifeOvarian CancerRecurrent Ovarian Carcinoma
Start date
2018-02-01
Primary completion
2023-08-08
Enrollment
89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.